Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Omer Basar"'
Autor:
Zahid Ijaz Tarar MD, Muhammad Usman Zafar MD, Umer Farooq MD, Omer Basar MD, Veysel Tahan MD, Ebubekir Daglilar MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 9 (2021)
Celiac disease (CD) is an autoimmune disorder that affects genetically predisposed individuals who are sensitive to gluten and related proteins. It affects children and adults with increasing prevalence in the older age groups. Both adaptive and inna
Externí odkaz:
https://doaj.org/article/28a7344e5f4746b4a77f0d917c1afcf0
Autor:
Karthik Gangu, Aniesh Bobba, Harleen Kaur Chela, Omer Basar, Robert W. Min, Veysel Tahan, Ebubekir Daglilar
Publikováno v:
Diseases, Vol 9, Iss 4, p 89 (2021)
Biliary tract diseases that are not adequately treated on index hospitalization are linked to worse outcomes, including high readmission rates. Delays in care for conditions such as choledocholithiasis, gallstone pancreatitis, and cholecystitis often
Externí odkaz:
https://doaj.org/article/a095ccb68545452095d62b519825da8a
Autor:
Omer Basar, William R. Brugge
Publikováno v:
Endoscopy International Open, Vol 04, Iss 12, Pp E1236-E1237 (2016)
Externí odkaz:
https://doaj.org/article/d4c33e6c56af4a91ba8342badfd0979d
Publikováno v:
Annals of Hepatology, Vol 11, Iss 5, Pp 728-730 (2012)
Externí odkaz:
https://doaj.org/article/b43515affb564ac5954e1b8f53e9a2ee
Autor:
Veysel Tahan, Burak C. Sevim, Harleen Chela, Hamza Ertugrul, Lyiba S. Malik, Suha Malik, Omer Basar, Ebubekir Daglilar, Sami Samiullah, Ayman H. Gaballah
Publikováno v:
Endocrine, Metabolic & Immune Disorders - Drug Targets. 23:485-493
Abstract: Non-alcoholic fatty pancreas disease (NAFPD) is a relatively new and emerging disease definition that is increasingly diagnosed every year, like non-alcoholic fatty liver disease (NAFLD). It is associated especially with metabolic syndrome
Publikováno v:
Gastroenterology Clinics of North America. 51:537-559
Early detection of high-risk pancreatic cystic lesions enables potentially curative surgical resection, and early detection of lesions without worrisome features may lead to appropriate surveillance. Regrettably, differentiating premalignant and mali
Autor:
Veysel Tahan, Mohamad Yousef, Harleen Chela, Hamza Ertugrul, Abdulmajeed Albarrak, Omer Basar, Syed Pasha, Yousef Mousa, Alhareth Al Juboori, Shellaine Frazier, Ebubekir Daglilar
Publikováno v:
Recent Advances in Inflammation & Allergy Drug Discovery. 17
Background: Lymphocytic esophagitis (LE) is a poorly understood clinical finding that has been increasingly identified in the last decade. Previous studies proposed increased frequency of LE in elderly females, as well as associations with smoking an
Autor:
Alexander Malik, Muhammad Nadeem Yousaf, Sami Samiullah, Tahan Veysel, Yuchu Sun, Amin Mahdi, Omer Basar
Publikováno v:
American Journal of Gastroenterology. 117:e2007-e2008
Autor:
Alexander Malik, Muhammad Nadeem Yousaf, John Abdelnour, Sami Samiullah, Tahan Veysel, Amin Mahdi, Omer Basar
Publikováno v:
American Journal of Gastroenterology. 117:e2025-e2026
Autor:
Zahid Ijaz Tarar, Umer Farooq, Faisal Kamal, Ahmad Nawaz, Saad Saleem, Ghulam Ghous, Omer Basar, Harleen Kaur Chela, Veysel Tahan, Ebubekir Daglilar
Publikováno v:
Postgraduate medical journal.
Background and aim Anticoagulation use for portal vein thrombosis (PVT) in patients with advanced liver disease is controversial. We investigated the effect of anticoagulation on outcomes in patients with PVT with cirrhosis. Methods We reviewed Natio